Matches in SemOpenAlex for { <https://semopenalex.org/work/W3009755280> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W3009755280 endingPage "51" @default.
- W3009755280 startingPage "47" @default.
- W3009755280 abstract "Background Flebogrif® (Balton, Poland) is a novel mechanochemical ablation (MOCA) device for saphenous vein insufficiency. It combines endothelial damage performed by radial retractable cutting hooks together with chemical ablation through sclerosant injection of 3% polidocanol foam according to its IFU. The objective of this study is to evaluate Flebogrif's efficacy in terms of recanalization rate and recurrence by varying polidocanol foam concentrations. Methods We performed 24 MOCAs on 23 patients with Flebogrif® between January and May 2019. In 12 cases the polidocanol foam was prepared at a 3% concentration, and in another 12 at 1.5%. Great saphenous vein (GSV) recanalization and truncular recurrence were evaluated at 1 and 3 months with a Duplex Ultrasound Anatomy (DUS) examination. Results At 1- and 3-month follow-ups, none of the 14 patients treated with the polidocanol 3% foam were observed to have had great saphenous vein GSV recanalization and truncular recurrence. Only 2 of the 14 (14.3%) cases treated with polidocanol 1.5% foam showed evidence of recanalization within the first centimetres from the sapheno-femoral junction (p > .05). All patients experienced clinical benefits without recurrence of symptoms. Conclusion MOCA with Flebogrif® is a safe, relatively inexpensive and effective alternative to standard methods in the treatment of saphenous insufficiency with encouraging short-term results. Despite our relatively small patient sample, no statistical significance in evidence of recurrence in the group of patients treated with 3% foam and those treated with 1.5% foam was noted. Longer term analysis of GSV patency and recurrence is necessary to further evaluate Flebogrif's impact and actual indications in the treatment of chronic venous disease." @default.
- W3009755280 created "2020-03-13" @default.
- W3009755280 creator A5003132917 @default.
- W3009755280 creator A5005764625 @default.
- W3009755280 creator A5015800619 @default.
- W3009755280 creator A5031674671 @default.
- W3009755280 creator A5053202973 @default.
- W3009755280 creator A5062284249 @default.
- W3009755280 date "2020-02-20" @default.
- W3009755280 modified "2023-09-27" @default.
- W3009755280 title "Early Results of Mechanochemical Ablation with Flebogrif® in great Saphenous Vein Insufficiency: does Polidocanol Concentration Affect Outcome?" @default.
- W3009755280 cites W1664566016 @default.
- W3009755280 cites W1978538314 @default.
- W3009755280 cites W2096073428 @default.
- W3009755280 cites W2107792820 @default.
- W3009755280 cites W2108518215 @default.
- W3009755280 cites W2115650583 @default.
- W3009755280 cites W2132987028 @default.
- W3009755280 cites W2136139586 @default.
- W3009755280 cites W2167096084 @default.
- W3009755280 cites W2168820012 @default.
- W3009755280 cites W2170635324 @default.
- W3009755280 cites W2399126058 @default.
- W3009755280 cites W2508754946 @default.
- W3009755280 cites W2529885002 @default.
- W3009755280 cites W2563239320 @default.
- W3009755280 cites W2592726075 @default.
- W3009755280 cites W2789659570 @default.
- W3009755280 cites W2797053426 @default.
- W3009755280 cites W2797838777 @default.
- W3009755280 cites W2801312303 @default.
- W3009755280 cites W2956063881 @default.
- W3009755280 cites W2994639487 @default.
- W3009755280 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7039266" @default.
- W3009755280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32123682" @default.
- W3009755280 hasPublicationYear "2020" @default.
- W3009755280 type Work @default.
- W3009755280 sameAs 3009755280 @default.
- W3009755280 citedByCount "0" @default.
- W3009755280 crossrefType "journal-article" @default.
- W3009755280 hasAuthorship W3009755280A5003132917 @default.
- W3009755280 hasAuthorship W3009755280A5005764625 @default.
- W3009755280 hasAuthorship W3009755280A5015800619 @default.
- W3009755280 hasAuthorship W3009755280A5031674671 @default.
- W3009755280 hasAuthorship W3009755280A5053202973 @default.
- W3009755280 hasAuthorship W3009755280A5062284249 @default.
- W3009755280 hasConcept C126322002 @default.
- W3009755280 hasConcept C141071460 @default.
- W3009755280 hasConcept C2776106345 @default.
- W3009755280 hasConcept C2777202286 @default.
- W3009755280 hasConcept C2777475103 @default.
- W3009755280 hasConcept C2778230777 @default.
- W3009755280 hasConcept C2778902805 @default.
- W3009755280 hasConcept C2779480337 @default.
- W3009755280 hasConcept C2780950165 @default.
- W3009755280 hasConcept C71924100 @default.
- W3009755280 hasConceptScore W3009755280C126322002 @default.
- W3009755280 hasConceptScore W3009755280C141071460 @default.
- W3009755280 hasConceptScore W3009755280C2776106345 @default.
- W3009755280 hasConceptScore W3009755280C2777202286 @default.
- W3009755280 hasConceptScore W3009755280C2777475103 @default.
- W3009755280 hasConceptScore W3009755280C2778230777 @default.
- W3009755280 hasConceptScore W3009755280C2778902805 @default.
- W3009755280 hasConceptScore W3009755280C2779480337 @default.
- W3009755280 hasConceptScore W3009755280C2780950165 @default.
- W3009755280 hasConceptScore W3009755280C71924100 @default.
- W3009755280 hasOpenAccess W3009755280 @default.
- W3009755280 hasVolume "21" @default.
- W3009755280 isParatext "false" @default.
- W3009755280 isRetracted "false" @default.
- W3009755280 magId "3009755280" @default.
- W3009755280 workType "article" @default.